Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA‐Seq-Reference-Cited by-同舟云学术

Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA‐Seq

Published:2021-07-21 Issue:17 Volume:25 Page:8271-8284
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhang Qi¹,Kuang Manchao¹,An Haiyin¹,Zhang Yajing¹,Zhang Kai²,Feng Lin¹,Zhang Lei³,Cheng Shujun¹^ORCID

Affiliation:

1. State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Endoscopy ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16773

Reference60 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The lung microenvironment: an important regulator of tumour growth and metastasis

3. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer

4. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

5. Lung cancer: current therapies and new targeted treatments

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased expression of individual genes in whole blood is associated with late-stage lung cancer at and close to diagnosis;Scientific Reports;2023-11-25

2. Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker;F1000Research;2022-11-11

3. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer;Cancers;2022-01-25